EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma

Adam P Yan iD, Rajkumar Venkatramani, Julie A Bradley, Timothy B Lautz, Cristian I Urla iD, Johannes H M Merks iD, Sapna Oberoi iD

Cancers · 14.04.2023 · 15 (8) · 2296

DOI: 10.3390/cancers15082296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.04.2023. Verfasst von Adam P Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON M5S 1R1, Canada. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RMS most commonly presents in children and adolescents, however a subset of tumors are diagnosed in infants under one year of age. Due to the rarity of infant RMS, utilization of different treatment approaches and goals, and small sample sizes, the published studies of infants with RMS have yielded heterogeneous results. In this review, we discuss the outcomes of infants with RMS treated in various clinical trials and the strategies that various international cooperative groups have employed to reduce the morbidity and mortality related to treatment without compromising the overall survival of this population. This review discusses the unique scenarios of diagnosing and managing congenitals or neonatal RMS, spindle cell RMS and relapsed RMS. This review concludes by exploring novel approaches to diagnosis and management of infants with RMS that are currently being studied by various international cooperative groups.

Schlagwörter

Stichwörter der Autor:innen

infantpediatricrhabdomyosarcomasarcoma

Autor:innen und Institutionen

  • Division of Pediatric Hematology Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON M5S 1R1, Canada.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Radiation Oncology, University of Florida, Jacksonville, FL 33024, USA.
  • Department of Surgery, Ann & Robert H Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL 60208, USA.
  • Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital of Tuebingen, Hoppe-Seyler-Strasse 3, 72076 Tuebingen, Germany.

ORCID-Profile: Adam P Yan, Cristian I Urla, Johannes H M Merks, Sapna Oberoi

Zitieren

APA

Yan, A. P., Venkatramani, R., Bradley, J. A., Lautz, T. B., Urla, C. I., Merks, J. H. M., & Oberoi, S. (2023). Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma. Cancers, 15(8), 2296. https://doi.org/10.3390/cancers15082296

Vancouver

Yan AP, Venkatramani R, Bradley JA, Lautz TB, Urla CI, Merks JHM, et al. Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma. Cancers. 2023;15(8):2296. doi:10.3390/cancers15082296

BibTeX
@article{Yan2023,
  author = {Yan, Adam P and Venkatramani, Rajkumar and Bradley, Julie A and Lautz, Timothy B and Urla, Cristian I and Merks, Johannes H M and Oberoi, Sapna},
  title = {Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {2296},
  doi = {10.3390/cancers15082296}
}
Kostenlos starten →